Skip to main content

GTS SECURITIES LLC

Broker-Dealer

Position in NVO — Novo Nordisk A S

CIK 1452765 NEW YORK, NY

Position in NVO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,597,801
+$3,374,387 QoQ
Shares Held
75,048
+1609.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#266
of 1,348 holders
Holding Since
Jun 2023
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Derivatives in NVO

reported options exposure · as of Sep 30, 2024
CallValue
$11,430,720
CallShares
96,000
PutValue
$12,228,489
PutShares
102,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

GTS SECURITIES LLC holds $12,976,736 across 10 Drug Manufacturers - General names. NVO ranks #1 (27.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NVO
Novo Nordisk A S
This page
75,048 $3,597,801

All Filings in NVO

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,597,801 75,048
2025-12-31 $223,414 4,391
2025-06-30 $218,310 3,163
2025-03-31 $217,833 3,137
2024-09-30 $11,430,720 96,000
2024-09-30 $1,063,176 8,929
2024-09-30 $12,228,489 102,700
2024-06-30 $12,561,120 88,000
2024-06-30 $15,758,496 110,400
2024-06-30 $1,546,873 10,837
2024-03-31 $3,595,071 27,999
2024-03-31 $11,851,320 92,300
2024-03-31 $10,426,080 81,200
2023-12-31 $12,155,375 117,500
2023-12-31 $1,552,474 15,007
2023-12-31 $5,348,365 51,700
2023-09-30 $14,659,528 161,200
2023-09-30 $1,151,027 12,657
2023-09-30 $12,849,822 141,300
2023-06-30 $2,765,189 17,087